tiprankstipranks
Trending News
More News >
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
Hong Kong Market
Advertisement

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Price & Analysis

Compare
0 Followers

2289 Stock Chart & Stats


Charmacy Pharmaceutical Co., Ltd. Class H News

2289 FAQ

What was Charmacy Pharmaceutical Co., Ltd. Class H’s price range in the past 12 months?
Charmacy Pharmaceutical Co., Ltd. Class H lowest stock price was HK$5.79 and its highest was HK$10.28 in the past 12 months.
    What is Charmacy Pharmaceutical Co., Ltd. Class H’s market cap?
    Charmacy Pharmaceutical Co., Ltd. Class H’s market cap is HK$629.64M.
      When is Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date?
      Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 203 days.
        How were Charmacy Pharmaceutical Co., Ltd. Class H’s earnings last quarter?
        Currently, no data Available
        Is Charmacy Pharmaceutical Co., Ltd. Class H overvalued?
        According to Wall Street analysts Charmacy Pharmaceutical Co., Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Charmacy Pharmaceutical Co., Ltd. Class H pay dividends?
          Charmacy Pharmaceutical Co., Ltd. Class H pays a Annually dividend of HK$0.489 which represents an annual dividend yield of 8.39%. See more information on Charmacy Pharmaceutical Co., Ltd. Class H dividends here
            What is Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate?
            Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Charmacy Pharmaceutical Co., Ltd. Class H have?
            Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding.
              What happened to Charmacy Pharmaceutical Co., Ltd. Class H’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Charmacy Pharmaceutical Co., Ltd. Class H?
              Currently, no hedge funds are holding shares in HK:2289

              Charmacy Pharmaceutical Co., Ltd. Class H Stock Smart Score

              2
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -24.07%
              12-Months-Change

              Fundamentals

              Return on Equity
              8.78%
              Trailing 12-Months
              Asset Growth
              2.88%
              Trailing 12-Months

              Company Description

              Charmacy Pharmaceutical Co., Ltd. Class H

              Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.

              Charmacy Pharmaceutical Co., Ltd. Class H (2289) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Shanghai Pharmaceuticals Holding Co
              Sinopharm Group Co
              ClouDr Group Limited
              IVD Medical Holding Limited
              Medlive Technology Co., Ltd.
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis